Sector | Healthcare | Compare with Sector peers |
Industry | Pharmaceuticals & Drugs | Compare with Industry peers |
Website | http://www.supriyalifescience.com | |
Market Cap | 3,304.22 Cr. | |
Enterprise Value(EV) | 3,188.51 Cr. | 2023-09 |
Financial Indicators | ||
---|---|---|
Earnings per share (EPS) | 14.96 | Trailing Twelve Months Ending 2023-12 |
Price-Earning Ratio (PE) | 27.44 | Trailing Twelve Months Ending 2023-12 |
Industry PE | 41.99 | Trailing Twelve Months Ending 2023-12 |
Book Value / Share | 97.28 | Trailing Twelve Months Ending 2023-12 |
Price to Book Value | 4.22 | Calculated using Price: 410.55 |
Dividend Yield | 0.15 | Period Ending 2023-03 |
No. of Shares Subscribed | 8.05 Cr. | 80,482,800 Shares |
FaceValue | 2 | |
About Supriya Lifescience Ltd. | ||
The company is one of the key Indian manufacturers and suppliers of active pharmaceuticals ingredients (APIs), with a focus on research and development. The company has niche product offerings of various APIs focused on diverse therapeutic segments such as antihistamine, analgesic, anaesthetic, vitamin, anti-asthmatic and antiallergic. |
1 Day |
|
-1.04% |
1 Week |
|
+11.67% |
1 Month |
|
+20.16% |
3 Month |
|
+32.48% |
6 Month |
|
+68.69% |
1 Year |
|
+87.67% |
2 Year |
|
-3.68% |
5 Year |
|
|
10 Year |
|
9 years | 2015-03 | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | 2023-03 | |
Return on Equity (%) | 29.61 | 17.2 | 15.05 | 18.38 | 53.11 | 60.42 | 59.17 | 34.34 | 13.66 | |
Return on Capital Employed (%) | 15.83 | 12.27 | 11.48 | 13.8 | 36.52 | 49.67 | 60.12 | 43.34 | 18.72 | |
Return on Assets (%) | 5.37 | 2.8 | 2.4 | 3.59 | 15.82 | 24.9 | 31.61 | 25.73 | 11.56 |
Particulars | 10 years | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-09* Rs. Cr. |
Shh. Funds | 37 | 42 | 46 | 55 | 94 | 149 | 269 | 616 | 699 | 753 | |
Non Curr. Liab. | 23 | 39 | 51 | 45 | 24 | 32 | 31 | 19 | 25 | 24 | |
Curr. Liab. | 115 | 150 | 144 | 146 | 135 | 155 | 146 | 100 | 96 | 66 | |
Minority Int. | |||||||||||
Equity & Liab. | 176 | 231 | 241 | 245 | 253 | 336 | 445 | 735 | 820 | 843 | |
Non Curr. Assets | 73 | 102 | 126 | 126 | 120 | 138 | 180 | 237 | 355 | 432 | |
Curr. Assets | 103 | 129 | 115 | 120 | 133 | 198 | 265 | 498 | 465 | 411 | |
Misc. Exp. not W/O | |||||||||||
Total Assets | 176 | 231 | 241 | 245 | 253 | 336 | 445 | 735 | 820 | 843 |
Particulars | 10 years | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-12 Rs. Cr. TTM |
Net Sales | 138 | 171 | 184 | 213 | 278 | 312 | 391 | 530 | 461 | 554 | |
Other Income | 2 | 2 | 7 | 9 | 8 | 11 | 5 | 8 | 10 | 10 | |
Total Income | 140 | 173 | 191 | 222 | 286 | 323 | 396 | 538 | 471 | 565 | |
Total Expenditure | -121 | -151 | -166 | -191 | -213 | -213 | -218 | -316 | -333 | -382 | |
PBIDT | 20 | 22 | 25 | 31 | 73 | 109 | 178 | 222 | 138 | 183 | |
Interest | -7 | -10 | -12 | -11 | -10 | -7 | -4 | -4 | -3 | -2 | |
Depreciation | -2 | -4 | -5 | -5 | -5 | -6 | -7 | -10 | -12 | -15 | |
Taxation | -2 | -2 | -2 | -6 | -18 | -23 | -44 | -55 | -34 | -45 | |
Exceptional Items | |||||||||||
PAT | 8 | 6 | 6 | 9 | 39 | 73 | 124 | 152 | 90 | 120 | |
Adjusted EPS | 1 | 1 | 1 | 1 | 5 | 10 | 17 | 19 | 11 | 15 |
Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. |
Cash Fr. Operatn. | 5 | -6 | 14 | 27 | 28 | 49 | 116 | 76 | 49 | 66 | |
Cash Fr. Inv. | -14 | -23 | -33 | -27 | -5 | 5 | -25 | -47 | -60 | -133 | |
Cash Fr. Finan. | 10 | 30 | 21 | -2 | -20 | -50 | -29 | -15 | 150 | -3 | |
Net Change | 1 | 1 | 2 | -2 | 3 | 4 | 62 | 15 | 139 | -70 | |
Cash & Cash Eqvt | 4 | 5 | 7 | 6 | 9 | 12 | 75 | 89 | 228 | 158 |
Thu, 25 Apr 2024
Analysts/Institutional Investor Meet/Con. Call Updates Supriya Lifescience Limited has informed the Exchange about Schedule of meet |
Fri, 19 Apr 2024
Analysts/Institutional Investor Meet/Con. Call Updates Supriya Lifescience Limited has informed the Exchange about Schedule of meet |
Wed, 10 Apr 2024
Certificate under SEBI (Depositories and Participants) Regulations, 2018 Supriya Lifescience Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018 |
Fri, 26 Apr 2024 |
Close Within 52 Week High Zone |
High Increase in 1 Month |
High Increase in 3 Months |
High Increase in 6 Months |
High Increase in 1 Year |